Healthcare & Life Sciences
Precision antibody-based therapeutics for oncology
series-b
series-b
Stage
1
Investors
About
Develops antibody-based therapeutic solutions targeting oncology indications to improve cancer treatment precision and efficacy.
Explore Precision antibody-based therapeutics for oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.